{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-090774","form_type":"8-K","ticker":"DH","cik":"0001861795","company_name":"Definitive Healthcare Corp.","filed_at":"2024-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.995269+00:00","generated_at":"2026-05-31T13:14:12.303766+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Definitive Healthcare Q2 revenue $63.7M (+5% YoY); net loss $(306.2)M on $363.6M goodwill impairment","bullets":["Revenue $63.7M (+5% YoY); net loss $(306.2)M including $363.6M goodwill impairment (up 2,538% from $(11.6)M).","Adjusted EBITDA $20.9M (33% margin) vs $17.2M; Adjusted Net Income $14.2M vs $12.4M.","Enterprise customers grew 6% YoY to 537; cash from ops $14.0M, unlevered FCF $21.5M.","Q3 2024 guidance: revenue $61-62.5M; adj. EBITDA $17.5-19M. FY2024 revenue $247-251M; adj. EBITDA $74-77M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-090774","json":"https://secwatch.observer/filing/0000950170-24-090774.json","markdown":"https://secwatch.observer/filing/0000950170-24-090774.md","text":"https://secwatch.observer/filing/0000950170-24-090774.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861795/000095017024090774/0000950170-24-090774-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861795/000095017024090774/dh-20240805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:14:12.303766+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}